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Abstract
Background: Alcohol consumption is a well-established risk factor for head and neck squamous cell carcinoma
(HNSCC); however, the molecular mechanisms by which alcohol promotes HNSCC pathogenesis and progression
remain poorly understood. Our study sought to identify microRNAs that are dysregulated in alcohol-associated
HNSCC and investigate their contribution to the malignant phenotype.
Method: Using RNA-sequencing data from 136 HNSCC patients, we compared the expression levels of 1,046
microRNAs between drinking and non-drinking cohorts. Dysregulated microRNAs were verified by qRT-PCR in
normal oral keratinocytes treated with biologically relevant doses of ethanol and acetaldehyde. The most
promising microRNA candidates were investigated for their effects on cellular proliferation and invasion,
sensitivity to cisplatin, and expression of cancer stem cell genes. Finally, putative target genes were identified
and evaluated in vitro to further establish roles for these miRNAs in alcohol-associated HNSCC.
Results: From RNA-sequencing analysis we identified 8 miRNAs to be significantly upregulated in alcohol-associated
HNSCCs. qRT-PCR experiments determined that among these candidates, miR-30a and miR-934 were the most highly
upregulated in vitro by alcohol and acetaldehyde. Overexpression of miR-30a and miR-934 in normal and HNSCC cell
lines produced up to a 2-fold increase in cellular proliferation, as well as induction of the anti-apoptotic gene BCL-2.
Upon inhibition of these miRNAs, HNSCC cell lines exhibited increased sensitivity to cisplatin and reduced matrigel
invasion. miRNA knockdown also indicated direct targeting of several tumor suppressor genes by miR-30a and miR-934.
Conclusions: Alcohol induces the dysregulation of miR-30a and miR-934, which may play crucial roles in HNSCC
pathogenesis and progression. Future investigation of the alcohol-mediated pathways effecting these transformations
will prove valuable for furthering the understanding and treatment of alcohol-associated HNSCC.
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Background
Based on incidence and mortality, head and neck squa-
mous cell carcinoma (HNSCC) is the 6th leading cancer
worldwide with an estimated 900,000 newly diagnosed
cases each year [1]. The major risk factors for HNSCC
include tobacco and alcohol, which account for at least
75 % of all cases diagnosed in Europe, the United States,
and other industrialized regions [2]. Tobacco use and al-
cohol consumption are two habits strongly linked with
each other that have been shown to act synergistically in
HNSCC, but many studies have also demonstrated each
substance to be an independent risk factor [2–5]. Des-
pite this knowledge, there is little evidence that people
have modified their alcohol intake, as alcohol consump-
tion has remained high throughout the years whereas to-
bacco usage has steadily declined [3, 4]. Meanwhile, a
molecular understanding of the pathogenesis of alcohol-
related HNSCC remains elusive and poorly understood.
Since ethanol alone is not considered a carcinogen, most
studies involving alcohol and cancer focus on its ability
to increase penetration of carcinogens, interfere with
DNA repair mechanisms, or cause DNA damage
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through acetaldehyde, the first metabolite of ethanol and
an established carcinogen [6, 7].
Recently, numerous studies have revealed that micro-
RNAs (miRNAs) play a role in the initiation and pro-
gression of many cancers, including HNSCC. miRNAs
are a class of non-coding RNAs 19–25 nucleotides in
length that can regulate gene expression by binding to
the partially complementary regions of messenger RNA
targets. It is proposed that miRNAs regulate up to a
third of protein coding genes, in turn impacting myriad
cellular processes including cellular growth, differenti-
ation, self-renewal, apoptosis, survival, and migration
[8, 9]. Analyzing the expression of miRNAs in cancer
compared to normal tissue and investigating the func-
tional significance of their dysregulation may be pivotal
for improving early diagnosis, predicting prognosis, and
establishing specific therapeutics. Several studies have
previously revealed aberrations in miRNA expression in
HNSCC tumors [10–12], but conclusive biomarkers
have yet to be established [8]. Furthermore, there is little
evidence about how miRNA dysregulation relates to
many HNSCC clinical risk factors, which may prove vital
for a clearer molecular understanding of how these fac-
tors play a role in carcinogenesis. One previous study
analyzed the association between four pre-selected
miRNAs and certain clinical features and risk factors, in-
cluding alcohol consumption. Using multivariate com-
parisons, it found that miR-375 was associated with
tumor site, stage, and alcohol consumption in HNSCC
[13]. Our study aimed to expand current understanding
of the link between alcohol consumption and miRNA
expression by using next-generation RNA-sequencing
data from 136 HNSCC patients to identify differentially
expressed candidates among 1,046 annotated miRNAs.
We subsequently investigated the alcohol-associated
miRNAs in normal oral keratinocyte cell cultures in
order to establish if these miRNAs may be crucial for
their malignant transformation. After selecting the miR-
NAs that were the most dysregulated by alcohol and
acetaldehyde, we evaluated how modulation of their ex-
pression would induce changes in cellular proliferation,
sensitivity to cisplatin, and invasion, and finally sought
to identify their mRNA targets The results of this study
demonstrate that alcohol consumption regulates several
miRNAs that likely play significant roles in the alcohol-
associated carcinogenesis of HNSCC.
Results
Identification of microRNAs associated with alcohol
consumption in HNSCC
From the TCGA database, we selected 136 HNSCC pa-
tients with miRNA-sequencing data providing normal-
ized expression values for 1,046 miRNAs, as well as
clinical data documenting both alcohol consumption
(drinks per day) and smoking status (pack-years
smoked). Using a Kaplan-Meier survival analysis, we
were able to verify that our patient cohort demonstrated
the risk of alcohol, with patients who consumed alcohol
experiencing significantly lower survival rates (Fig. 1a).
To account for the two major risk factors of HNSCC,
we sorted our patient cohort into 4 groups: (1) non-
smoking non-drinkers, (2) nonsmoking drinkers, (3)
smoking non-drinkers, and (4) smoking drinkers
(Table 1). In order to identify miRNAs that were dysreg-
ulated due to alcohol consumption alone, we compared
miRNA expression in drinkers and non-drinkers within
both the smoking and non-smoking cohorts. Addition-
ally, we compared miRNA expression and drinkers and
non-drinkers using the entire patient population, regard-
less of smoking status (Fig. 1b-c). From our analysis, we
identified 8 miRNAs that were significantly upregulated
(p < 0.05) in alcohol consumers compared to non-
drinkers in all three of our comparisons (Fig. 1d-e,
Table 2).
In vitro ethanol treatment validates alcohol-induced
microRNA dysregulation
In order to verify that the miRNAs we identified were
associated with alcohol consumption, we performed in
vitro ethanol treatment using early passage oral epithelial
culture cells OKF4 and OKF6. We used normal oral epi-
thelial cells in order to address whether alcohol directly
promotes dysregulation of our identified miRNAs as an
early event in malignant transformation. We first
assessed the viability of our cell lines under a large range
of ethanol doses (0-10 % by volume) over 48 h using an
MTS assay and found that there was no significant tox-
icity up to 1 % (Additional file 1: Figure S1). In order to
mimic short- and long-term exposure to alcohol, we
treated our cell cultures with biologically relevant con-
centrations of ethanol for a period of 1, 2, or 4 weeks,
using a range of doses resembling the blood alcohol
levels attained by social drinkers to heavy drinkers, 0.1 %
(17 mM) and 0.3 % (51 mM) by volume, respectively,
with 1 % (51 mM) ethanol serving as the upper limit
control (see Methods). Of the eight miRNAs that we
identified from the clinical data, miR-30a-5p, miR-934,
miR-3164, and miR-3178 were upregulated from long-
term (4-week) ethanol exposure in both OKF4 and
OKF6 (Figs. 2a and c). Additionally, two other miRNAs,
miR-133a and miR-3138, were upregulated in the
alcohol-consuming patients in two categories and also
verified in vitro (Fig. 2c). We next sought to investigate
what duration of ethanol exposure in the normal cells
was sufficient to induce overexpression of these miR-
NAs. While 1-week ethanol exposure resulted in the up-
regulation of miR-934 and miR-3178 in OKF4
(Additional file 1: Figure S1), we found that 4-week
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Fig. 1 (See legend on next page.)
Saad et al. Molecular Cancer  (2015) 14:181 Page 3 of 14
ethanol exposure was necessary in order to generate
consistent upregulation of the miRNAs of interest. In
addition, we exposed the established HNSCC cell lines
UMSCC-10B and UMSCC-22B to ethanol in order to
assess the dysregulation of our candidate miRNAs in
cancer cells. Shorter-term 1- and 2-week ethanol treat-
ments were both sufficient to result in overexpression of
miR-30a, miR-934, miR-3138, miR-3164, and miR-3178
(Fig. 2e).
In vitro acetaldehyde treatment further validates alcohol-
induced microRNA dysregulation
Although alcohol consumption has been determined to
be an independent risk factor for HNSCC, the precise
Table 1 Summary of patient demographics and clinicopathological characteristics (n = 136)
Non–Drinker (27) Drinker (109)
All No. (%) Smoker No. (%) Non–Smoker No. (%) Smoker No. (%) Non–Smoker No. (%)
Gender
Male 109 (80 %) 9 (60 %) 8 (67 %) 86 (86 %) 7 (78 %)
Female 27 (20 %) 6 (40 %) 4 (34 %) 14 (14 %) 2 (22 %)
Lifetime pack–years smoked a
None 21 (15 %) 0 (0 %) 0 (0 %)
>0–40 40 (29 %) 7 (47 %) N/A 32 (32 %) N/A
>40 49 (36 %) 4 (27 %) 44 (44 %)
Drinks per day
None 27 (20 %) 0 (0 %) 0 (0 %)
0–2 25 (18 %) N/A N/A 20 (20 %) 5 (56 %)
>2 84 (62 %) 80 (80 %) 4 (44 %)
Vital Status
Deceased 42 (31 %) 6 (40 %) 2 (17 %) 33 (33 %) 1 (11 %)
Living 94 (69 %) 9 (60 %) 10 (83 %) 67 (67 %) 8 (89 %)
Tumor Site
Oral 92 (68 %) 12 (80 %) 9 (75 %) 65 (65 %) 6 (67 %)
Pharyngeal 15 (11 %) 0 (0 %) 3 (25 %) 9 (9 %) 3 (33 %)
Laryngeal 29 (21 %) 3 (20 %) 0 (0%) 26 (26 %) 0 (0 %)
Stage b
Low (I, II) 28 (25 %) 2 (13 %) 2 (29 %) 23 (28%) 1 (14 %)
High (III, IV) 84 (75 %) 13 (87 %) 5 (71 %) 60 (72%) 6 (86 %)
Grade
GX 4 (3 %) 0 (0 %) 0 (0 %) 3 (3 %) 1 (11 %)
G1–G2 92 (68 %) 13 (87 %) 9 (75 %) 65 (65 %) 5 (56 %)
G3–G4 40 (29 %) 2 (13 %) 3 (25 %) 32 (32 %) 3 (33 %)
Total: 136 15 12 100 9
a26 patient data not available
b24 patient data not available
(See figure on previous page.)
Fig. 1 RNA-sequencing analysis identifies 8 microRNAs that are associated with alcohol consumption. (a) Kaplan-Meier analysis indicates that increased
alcohol consumption leads to poorer patient survival in our patient population (n= 42). (b) Venn diagram schematic conveying our approach to determine
the 8 alcohol-associated miRNAs. Each circle represents a comparison of the drinkers versus non-drinkers in each of the categories (smokers, non-smokers,
or inclusion of all patients). (c) Heatmaps represent the reads per million miRNA mapped (RPKM) of the most statistically significant dysregulated miRNAs
between drinkers and non-drinkers. miRNAs are listed by order of p-value with the most significant located towards the top. (d) Log-transformed miR-30a
and (e) miR-934 expression levels in drinkers versus non-drinkers. The middle bar represents the mean, the top and bottom borders represent the 25th and
75th percentile, and the whiskers reach the 5th and 95th percentile. The circles represent outliers
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mechanism by which alcohol exerts this effect remains
unclear, since ethanol itself is not carcinogenic. It has
been postulated that acetaldehyde, the first metabolite of
ethanol, contributes to alcohol-associated cancer risk, as
it has been shown to produce mutagenic effects such as
chromosomal aberrations and DNA cross-links [6].
While the bulk of alcohol metabolism is carried out in
the liver, it may also take place via intracellular enzymes
in the esophageal and oral mucosa [7] . Furthermore,
acetaldehyde is also formed in high concentrations in
saliva by the oral microflora [14] . In order to further
verify that our selected miRNAs play a role in alcohol-
related pathogenesis, we used physiologically relevant
doses of acetaldehyde as determined by saliva concentra-
tions in alcohol consumers [14], ranging from 75 μM to
300 μM to represent light to heavy drinking habits. A
24 h MTS assay was performed to test a large range of
acetaldehyde doses and their effects on cellular viability.
We show that at the clinically relevant doses, there is an
inconsequential difference in cellular proliferation
(Additional file 1: Figure S1). Upon exposure to acetal-
dehyde treatment, the normal epithelial cells showed a
similar increase in expression of the same 6 miRNAs as
the long-term ethanol treatment (Fig. 2b and d). Mean-
while, acetaldehyde-exposed UMSCC-10B and UMSCC-
22B similarly overexpressed miR-30a, miR-934, miR-3138,
miR-3164, and miR-3178 (Fig. 2f). Taken together, our
in vitro data suggests that the dysregulation of these
miRNAs are associated with alcohol consumption and
metabolism, and may even play an early role in the malig-
nant transformation of normal oral cells.
Overexpression of miR-30a and miR-934 induces the ex-
pression of BCL-2 and increases cellular proliferation
To functionally characterize the effects of our identified
alcohol-regulated miRNAs, we investigated their influ-
ence on cellular proliferation as well as their relationship
with established cancer genes, including the anti-
apoptotic gene BCL-2. We selected miR-30a-5p and
miR-934 for functional characterization, as they were the
most consistently dysregulated in the clinical data, etha-
nol treatments, and acetaldehyde treatments. Experi-
ments were performed in the HNSCC cell lines
UMSCC-10B and UMSCC-22B as proof of principle,
since the normal early passage cell cultures are highly
sensitive to transfection reagents. Transfection efficiency
Table 2 List of 8 identified microRNAs and their corresponding fold changes and p-values
miRNA ID Fold change (Drinkers/Nondrinkers) P-value Comparison
hsa-mir-3178 7.59 0.0398 Drinkers Vs. Nondrinkers (Non-smokers)
5.18 0.0004 Drinkers Vs. Nondrinkers (Smokers)
5.77 1.4659E-05 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-675 3.57 0.0221 Drinkers Vs. Nondrinkers (Non-smokers)
8.07 0.0012 Drinkers Vs. Nondrinkers (Smokers)
5.48 0.0009 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-934 5.99 0.0164 Drinkers Vs. Nondrinkers (Non-smokers)
4.19 0.0237 Drinkers Vs. Nondrinkers (Smokers)
4.74 0.0122 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-101 2.31 0.0491 Drinkers Vs. Nondrinkers (Non-smokers)
1.25 0.0337 Drinkers Vs. Nondrinkers (Smokers)
1.76 0.0042 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-1266 3.82 0.0163 Drinkers Vs. Nondrinkers (Non-smokers)
1.53 0.0322 Drinkers Vs. Nondrinkers (Smokers)
2.60 0.0018 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-30a 1.65 0.0383 Drinkers Vs. Nondrinkers (Non-smokers)
1.67 0.0052 Drinkers Vs. Nondrinkers (Smokers)
1.66 0.0013 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-3164 21.12 0.0469 Drinkers Vs. Nondrinkers (Non-smokers)
6.71 0.0208 Drinkers Vs. Nondrinkers (Smokers)
1.94 0.0375 Drinkers Vs. Nondrinkers (Overall)
hsa-mir-3690 2.79 0.0429 Drinkers Vs. Nondrinkers (Non-smokers)
1.63 0.0349 Drinkers Vs. Nondrinkers (Smokers)
2.12 0.0026 Drinkers Vs. Nondrinkers (Overall)
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for all experiments was greater than 70 % and the over-
expression of each miRNA, in each cell line, was mea-
sured by qRT-PCR (Fig. 3a). Overexpression of miR-30a
and miR-934 increased the expression of BCL-2 in both
UMSCC-10B and UMSCC-22B (Fig. 3b). To test effects
on proliferation, an Alamar blue assay and an MTS assay
were each performed on miR-30a-5p and miR-934-trans-
fected UMSCC-10B and UMSCC-22B. Both miRNAs
promoted increased proliferation, with with miR-30a
and miR-934 inducing nearly 3-fold increases over an
experiment period of 3 days in UMSCC-22B (Fig. 3c-d).
Inhibition of miR-30a and miR-934 sensitizes cells to
cisplatin and decreases cellular invasion
Since endogenous expression of miR-30a and miR-934
was higher in HNSCC cell lines compared to normal cell
lines (Fig. 4a), we inhibited both miRNAs in the HNSCC
cell lines UMSCC-10B and UMSCC-22B to further
characterize their functional effects. Knockdown of both
miRNAs was performed with anti-miRs and produced at
least a 75 % reduction in miRNA expression (Fig. 4b).
We first performed an MTS assay to test the effects of
cisplatin on miR-30a- and miR-934-inhibited UMSCC-
10B and UMSCC-22B. Our results show that knock-
down of the miRNAs sensitizes the cells to cisplatin-
mediated cell death, even though inhibition of the miR-
NAs alone had a limited effect on cellular proliferation
(Fig. 4c). Additionally, matrigel invasion assays were per-
formed to evaluate the roles of these miRNAs in regulat-
ing cellular invasion. Inhibition of miR-934 resulted in
up to 56 % reduction in invasive abilities, while inhib-
ition of miR-30a caused up to 40 % reduction (Fig. 4d).
miR-30a and miR-934 regulate expression of predicted
target tumor suppressor genes
To further define molecular roles for miR-30a and miR-
934 in HNSCC, we identified candidate mRNA targets
for both miRNAs using two target prediction algorithms.
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Fig. 2 Ethanol and acetaldehyde treatment in normal culture cells verifies clinical data analysis of alcohol-dysregulated microRNAs. (a) qRT-PCR
demonstrates that long-term ethanol treatment of normal oral epithelial cells upregulates miR-30a and miR-934 in OKF4 and OKF6. (b) qRT-PCR
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The tumor suppressor genes BNIP3L, PRDM9, and
SEPT7 were each found to have direct 3’UTR binding
sites with miR-30a-5p (Fig. 5a). Meanwhile, tumor sup-
pressors HIPK2, HOXA4, and MLL3 were predicted to
be similarly targeted by miR-934 (Fig. 5c). Next, we eval-
uated the expression levels of these putative targets fol-
lowing knockdown of miR-30a and miR-934 in UMSCC-
10B and UMSCC-22B. Inhibition of miR-30a induced
significant upregulation of BNIP3L, PRDM9, and SEPT7
(Fig. 5b), while inhibition of miR-934 increased the ex-
pression of HIPK2, HOXA4, and MLL3 (Fig. 5c), suggest-
ing that the miRNAs exert negative regulatory effects on
these established tumor suppressors.
Discussion
Although alcohol consumption has been identified as a
potent risk factor for HNSCC, knowledge regarding its
functional role as an independent etiological agent for
the disease remains significantly limited. Multiple studies
have proposed that the action of alcohol in HNSCC
pathogenesis is mediated by its first metabolite acetalde-
hyde, a well-established carcinogen [15], but others have
postulated that alcohol may exert adverse effects dir-
ectly, either by increasing the cellular uptake and po-
tency of carcinogens such as tobacco [16], or by
inducing DNA hypomethylation [17]. The relevance of
these proposed models to alcohol-associated HNSCC
and the molecular mechanisms by which they may occur
have remained obscure; previous investigations of the ef-
fects of environmental factors on genetic and epigenetic
alterations in HNSCC have largely focused on character-
izing tobacco, HPV exposure, or tobacco in association
with alcohol [1, 18, 19].
We are the first to globally profile alcohol-induced
miRNA dysregulation in HNSCC and to functionally
characterize the roles that these miRNAs may play in
HNSCC pathogenesis and progression. Through RNA-
sequencing analysis of miRNA expression in 136
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patients, we identified a panel of 8 miRNAs (miR-3178,
miR-675, miR-934, miR-101, miR-1266, miR-30a, miR-
3164, and miR-3690) exhibiting significant upregulation
in alcohol-associated HNSCCs, suggesting their role as
oncomirs. By subdividing our patient cohort into
smokers and non-smokers, and comparing the drinking
and non-drinking populations within both groups for
unifying miRNA aberrations, we ensured that these
miRNA candidates were dysregulated due to alcohol
consumption alone, removing the synergistic and likely
confounding influence of tobacco.
None of the 8 miRNAs have been previously identified
in studies of tobacco or HPV-induced miRNA dysregula-
tion in HNSCC [1]. Furthermore, miR-3164 and miR-
3690 demonstrate no previous connections to cancer, es-
tablishing them as potentially fruitful targets for future
investigation. Such findings underscore existing evidence
of considerable heterogeneity in the genetic and tran-
scriptional landscapes of HNSCCs associated with differ-
ent etiologies [1, 18], and pose implications for future
distinctions in the diagnostic strategies and clinical man-
agement of alcohol-associated HNSCC.
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Interestingly, previous studies of miR-1266 and miR-
3678 characterize their roles as tumor suppressor miR-
NAs in gastric cancer. miR-1266 was downregulated in
gastric cancer tissues and was shown to inhibit tumor
growth and invasion by targeting telomerase reverse
transcriptase (hTERT) [20], while miR-3678 was found
to be significantly downregulated in lymphatic metasta-
ses [21]. Meanwhile, there exists conflicting evidence re-
garding the roles of miR-675 and miR-101 in various
malignancies. miR-675, along with its precursor long
non-coding RNA H19, was found to inhibit invasion and
metastasis in hepatocellular carcinomas [22], but was
shown to promote the pathogenesis and metastasis of
gastric cancer and target the tumor suppressor retino-
blastoma in colorectal cancer [23, 24]. Similarly, studies
in a number of cancers have found miR-101 to function
as a tumor suppressor by targeting EZH2 [24, 25], yet it
was also implicated as a promoter of growth in estrogen
receptor (ER)-positive breast tumors by inducing the ac-
tivation of Akt [25]. While further investigation of these
discrepancies may be necessary, there is mounting evi-
dence that miRNAs may assume tissue-specific or
Fig. 5 miR-30a and miR-934 knockdown in HNSCC cell lines results in the upregulation of predicted tumor suppressor target genes. (a) Putative
sequences targeted by miR-30a within the 3’ UTR of BNIP3L, PRDM1, and SEPT7. (b) The three predicted targets are significantly upregulated in the
UMSCC-10B and UMSCC-22B cell lines following inhibition of miR-30a (48 h). (c) Putative sequences targeted by miR-934 within the 3’ UTR of
HOXA4, HIPK2, and MLL3. (d) The three predicted targets exhibit increased expression in UMSCC-10B and UMSCC-22B 48 h after knockdown of
miR-934. All data is presented as the mean and error bars represent standard deviation. *p<0.05, **p<0.01, ***p<0.001, Student’s t-test
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cancer-specific targets and functions via distinct path-
ways [26, 27]. Therefore, future characterizations of the
miRNAs we have identified may find that they indeed
exert unique effects in the contexts of HNSCC and
alcohol-induced dysregulation.
We found miR-30a, miR-934, miR-3164, and miR-3178
to be consistently upregulated in oral keratinocytes and
HNSCC cell lines following treatments with ethanol and
acetaldehyde, demonstrating that dysregulation of these
miRNAs is directly mediated by exposure to alcohol and
is likely involved in both the early stages of malignant
transformation and the progression to increased malig-
nancy in HNSCC. Notably, acetaldehyde alone also in-
duced aberrant expression of the miRNAs, implying that
its carcinogenic properties are not only the result of
DNA cross-links and chromosomal aberrations as previ-
ously characterized [6], but also due to its modulation of
miRNA-mediated pathways. These findings also confirm
that ethanol-to-acetaldehyde metabolism is responsible,
at least in part, for alcohol-related HNSCC pathogenesis.
Interestingly, however, the 4 miRNAs failed to exhibit
proportional increases in expression in response to in-
creased ethanol or acetaldehyde dosage, with strongest
upregulation generally occurring at the lowest ethanol
(0.1 %) and acetaldehyde (75 μM) concentrations. This
may simply indicate that alcohol-mediated miRNA dys-
regulation is governed by factors other than intake
levels; a previous study of the relationship between car-
cinogen exposure and homozygous deletion of p16INK4A
in HNSCCs found that the duration, rather than inten-
sity, of tobacco and alcohol use significantly predicted
deletion frequency [28]. Further investigation of the rela-
tionship between length of alcohol consumption and
miRNA expression, in conjunction with the in vitro ex-
periments presented here simulating long-term alcohol
exposure, may therefore be valuable in characterizing
more precisely the conditions under which alcohol-
induced miRNA dysregulation occurs.
In particular, we show that enforced expression of
miR-30a and miR-934 in HNSCC cell lines promotes the
induction of anti-apoptotic gene BCL-2, as well as in-
creased cellular proliferation in the HNSCC cell lines.
Conversely, inhibition of the miRNAs in HNSCC re-
sulted in reduced invasion, as well as decreased resist-
ance to cisplatin. The potential of these alcohol-
dysregulated miRNAs to confer proliferative and invasive
properties to HNSCC cells may significantly account for
the elevated risks of developing HNSCC and experien-
cing tumor recurrence that have been observed in
drinkers [2–5]. Furthermore, the ability of miRNA sup-
pression to sensitize cells to cisplatin and decrease inva-
sive capabilities establishes miR-30a and miR-934 as
potential targets of future therapies specifically tailored
to alcohol-related HNSCC. Our findings are consistent
with previous studies reporting the ability of miR-934
and miR-30a to promote metastasis as well: miR-934,
along with host gene VGLL1, was found to be upregu-
lated in ER-negative BRCA1-positive breast cancers and
was associated with the acquisition and maintenance of
luminal progenitor characteristics [29]; similarly, miR-
30a was shown to promote invasion in nasopharyngeal
carcinoma (NPC) via the repression of E-cadherin and
induction of epithelial-to-mesenchymal transition
(EMT) [30].
The putative target genes we have shown to be modu-
lated by both miRNAs further corroborate their pro-
posed roles in HNSCC. BNIP3L, potential target of miR-
30a, is a proapoptotic gene activated by p53 under hyp-
oxic conditions [31, 32]. Meanwhile, SEPT7 is a cell
cycle regulator involved in kinetochore localization and
apoptosis [33, 34], and PRDM1 is a transcriptional re-
pressor and inhibitor of the Wnt signaling pathway [35],
which has been shown to be centrally associated with
stemness and invasiveness in HNSCCs [36].
Both SEPT7 and PRDM1 have been found to be tar-
geted by miR-30a in gliomas [35, 37]. The proposed tar-
gets for miR-934 are also potent tumor suppressors:
HOXA4 has been shown to inhibit cell motility and inva-
sion in ovarian carcinoma [38]; MLL3 is involved in a
p53 coactivator complex, with knockout resulting in epi-
thelial tumor formation in mice [39]; and HIPK2 medi-
ates apoptosis and activates p53 via phosphorylation at
Ser46 [40].
Conclusions
Taken together, our findings indicate a novel interplay
between alcohol-mediated dysregulation of miRNAs and
key tumorigenic and metastatic processes in HNSCC.
Specifically, we have shown that miR-30a and miR-934
are upregulated in HNSCC patients who are drinkers
and that miR-30a and miR-934 expression in HNSCC
cell lines produced changes in cellular proliferation and
invasion, as well as differential targeting of key tumor
suppressors. Studies further evaluating miR-30a and
miR-934 in the context of alcohol-induced EMT, along
with investigations of other roles of ethanol and acetal-
dehyde in EMT-associated pathways, may substantially
enhance our molecular understanding of alcohol-
associated HNSCC and catalyze the development of tar-
geted diagnostics and therapies for the disease.
Methods
miRNA-sequencing datasets and differential expression
analysis
Level 3-normalized miRNA expression datasets and clin-
ical data for 136 HNSCC patients were obtained from
The Cancer Genome Atlas (TCGA) (https://tcga-data.
nci.nih.gov/tcga).These patients were separated into four
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cohorts based on reported alcohol and tobacco use, in
order to minimize the confounding influence of smoking
on HNSCC prevalence and pathogenesis: (1) nonsmok-
ing non-drinkers, (2) nonsmoking drinkers, (3) smoking
non-drinkers, and (4) smoking drinkers (Table 1). Statis-
tical analyses were performed using IBM SPSS Statistics
v.22. To account for unequal variance, two-tailed
Welch’s t-tests were used for the differential expression
analyses. Only p-values below 0.05 were considered sta-
tistically significant.
Survival analysis
42 HNSCC patients in the TCGA database had available
data for both alcohol consumption and length of sur-
vival. All of these patients were smokers and were subdi-
vided into non-drinkers, light drinkers (1–3 drinks per
day) and heavy drinkers (more than 3 drinks per day).
Kaplan-Meier plots were graphed using IBM SPSS Sta-
tistics v.22 and a log-rank test was used to calculate the
p-value. Only p-values <0.05 were considered statistically
significant.
Cell culture and treatment with ethanol and acetaldehyde
Normal, early passage, oral epithelial cell linesOKF4 and
OKF6 (derived from the floor of the mouth) were gifts
from the Rheinwald Lab at Harvard Medical School.
The cells were cultured in keratinocyte serum-free
media (Life Technologies) supplemented with EGF, bo-
vine pituitary extract, 2 % L-glutamine, 2 % penicillin/
streptomycin, and CaCl2. These cells were either ex-
posed to ethanol for 1 week or 4 weeks, or to acetalde-
hyde (Sigma Aldrich) for 48 h.
The HNSCC cell lines UMSCC-10B and UMSCC-22B
(derived from laryngeal and hypopharyngeal tumors, re-
spectively) were gifts from Dr. Tom Carey, University of
Michigan. The cells were cultured in DMEM supple-
mented with 10 % fetal bovine serum, 2 % penicillin/
streptomycin, and 2 % L-glutamate (GIBCO) and main-
tained at 37 °C in a humidified 5 % CO2/95 % air atmos-
phere. These cells were either exposed to ethanol for 1,
2, or 4 weeks, or to acetaldehyde for 48 h.
The doses used for ethanol treatment were 0.1 %,
0.3 %, and 1 % by volume (approximate concentrations
17 mM, 51 mM, and 170 mM, respectively). We chose
the 0.1 % (17 mM) dose to represent social drinking
habits, as 0.1 % is the blood alcohol level constituting
legal intoxication in the U.S. [41]. The 0.3 % (51 mM)
ethanol dose was used to simulate binge drinking habits,
as it is representative of the blood alcohol levels of mod-
erate to heavy drinkers [42]. The 1 % (170 mM) ethanol
dose, while potentially lethal in humans, was employed
as an upper limit control as it was the highest concen-
tration that was minimally toxic to the oral keratinocytes
(Additional file 1: Figure S1). For all ethanol-culture
experiments, treatment media was replaced every 24 h
with fresh media containing the stated ethanol concen-
tration. The tissue culture plates were also sealed with
paraffin film to reduce evaporative loss of ethanol from
the media. It has been shown that sealed culture vessels
are able to maintain ethanol concentrations over signifi-
cantly longer incubation periods [43].
The doses used for acetaldehyde treatment were
75 μM, 150 μM, and 300 μM, to represent a range of
light to heavy drinking as determined by the saliva con-
centrations of alcohol consumers [14]. To account for
the short evaporation half-life of acetaldehyde, treat-
ments were performed every 4 h and the tissue culture
plates were also sealed with paraffin film.
microRNA expression profiling by qRT-PCR
Total RNA was isolated (Fisher Scientific) from cultured
cells after their respective treatments with ethanol or
acetaldehyde. cDNA was synthesized using the Quanti-
MiRTM RT kit (System Biosciences, Mountain View,
CA) as per the manufacturer’s instructions. Real-time
PCR reaction mixes were created using FastStart Univer-
sal SYBR Green Master Mix (Roche Diagnostics), and
run on a StepOnePlusTM Real-Time PCR System (Ap-
plied Biosystems) using the following program: 50 °C for
2 min, 95 °C for 10 min, 95 °C for 30 s, and 60 °C for
1 min, for 40 cycles. Experiments were analyzed using
the ddCt method. U6 primers and a Universal Reverse
Primer were used from the QuantiMiRTM RT kit, and
custom primers (Eurofins MWG Operon) were ordered
using the following sequences: miR-3178: 5’-GGGGCGCG
GCCGGATCG-3’, miR-675: 5’-TGGTGCGGAGAGG
GCCCACAGTG-3’, miR-934: 5’-TGTCTACTACTGGAGA
CACTGG-3’, miR-101: 5’-CAGTTATCACAGTGCTG
ATGCT-3’, miR-1266: 5’-CCTCAGGGCTGTAGAAC
AGGGCT-3’, miR-30a: 5’-TGTAAACATCCTCGACT
GGAAG-3’, miR-3164: 5’-TGTGACTTTAAGGGAAA
TGGCGAA-3’, and miR-3690: 5’-ACCTGGACCCAG
CGTAGACAAAG-3’.
microRNA plasmid and siRNA transfections
Expression plasmids for human miR-30a and miR-934
(OriGene Technologies, Rockville, MD) were transiently
transfected using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA), following the manufacturer’s specifications.
The pCMV-MIR empty vector was used as control and
transfection efficiency for all three plasmids was moni-
tored using GFP as a reporter.
Knockdown of both miRNAs was performed using
Anti-miRTM miRNA inhibitors (Ambion, Austin, TX)
that were specific for miR-30a-5p and miR-934.
These inhibitors were also transfected with Lipofec-
tamine 2000.
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qRT-PCR for BCL-2 gene expression
Total RNA was collected 48 h after transfection with
miRNA expression plasmids or inhibitors (Fisher Scien-
tific). cDNA was synthesized using Superscript III Re-
verse Transcriptase (Invitrogen, Carlsbad, CA) as per the
manufacturer’s instructions. Real-time PCR reaction
mixes were created using FastStart Universal SYBR
Green Master Mix (Roche Diagnostics), and run on a
StepOnePlusTM Real-Time PCR System (Applied Biosys-
tems) following the previously described program. Re-
sults were analyzed using the ddCt method, with
GAPDH expression as the endogenous control. Primers
were custom ordered (Eurofins MWG Operon, Hunts-
ville, AL) using the following sequences: GAPDH for-
ward: 5′-CTTCGCTCTCTGCTCCTCC-3′, reverse:
5′-CAATACGACCAAATCCGTTG −3′. BCL-2 for-
ward: 5’-CCTGTGGATGACTGAGTACC-3’, reverse:
5’-CCTGTGGATGACTGAGTACC-3’.
Alamar blue cell viability assay
UMSCC-10B and UMSCC-22B cells were plated into a
96-well flat-bottom tissue culture plate (Falcon) at a
density of 2,000 cells per well. After a 24 h plating
period, these cells were transfected with the miRNA ex-
pression plasmids. After a 48 h incubation period, cellu-
lar proliferation was analyzed using Alamar blue reagent
(ThermoFisher) in accordance with the manufacturer's
protocol. All assays were performed in triplicate wells
and experiments were individually performed at least
twice.
MTS cell proliferation assay
UMSCC-10B and UMSCC-22B cells were plated into a
96-well flat-bottom tissue culture plate (Falcon) at a
density of 5,000 cells per well. After a 24 h plating
period, these cells were transfected with the miRNA ex-
pression plasmids or inhibitors. For cisplatin sensitivity
experiments, the control and transfected cells were sub-
sequently exposed to one of several doses of cisplatin
ranging from 0–5 μg/mL. After a 48 h incubation
period, cellular proliferation was analyzed using an MTS
proliferation assay (Promega) in accordance with the
manufacturer's protocol. All assays were performed in
triplicate wells and experiments were individually per-
formed at least twice.
Matrigel invasion assay
Invasion of UMSCC-10B and UMSCC-22B cells was
measured using a Matrigel invasion assay (Becton Dick-
inson, Bedford, MA). 48 h post transfection with either
the expression plasmid or inhibitor, cells were trypsi-
nized, and 500 μL of cell suspension (1 × 105 cells/mL)
was added in triplicate wells. The lower chamber of the
transwell was filled with 750 μl of culture media
containing 0.5 % serum as a chemoattractant and
allowed to incubate at 37 °C for 24 h. Invading cells on
the lower surface that passed through the filter were
fixed and stained using crystal violet in gluteraldehyde
and photographed. The number of the stained nuclei
was counted in a predetermined and consistent section
of each well.
miRNA target gene identification and qRT-PCR
Putative mRNA targets of miR-30a-5p and miR-934
were selected using the TargetScan (v6.2) (http://
www.targetscan.org/) and miRDB (v5.0) (http://mird-
b.org/miRDB/) target prediction algorithms based on
miRNA seed region complementarity in the mRNA
3’UTR.
Total RNA was collected from UMSCC-10B and
UMSCC-22B 48 h after transfection with miR-30a and
miR-934 inhibitors. cDNA was synthesized using Super-
Script III Reverse Transcriptase and qRT-PCRs were per-
formed as previously described, with GAPDH serving as
endogenous control. Primers for the target genes were cus-
tom synthesized (Eurofins MWG Operon) using the follow-
ing sequences: GAPDH forward: 5′-CTTCGCTCTCTG
CTCCTCC-3′, reverse: 5′-CAATACGACCAAATCCGT
TG −3′. BNIP3L forward: 5’- GGACTCGGCTTGTTG
TGTTG-3’, reverse: 5’-AGACTGCTCATTTTCCTCGCA-
3’. PRDM1 forward: 5’-TAACACAGACAAAGTGCTGCC-
3’, reverse: 5’-CTACCCAGTCCACATTCTCCC-3’. SEPT7
forward: 5’-ATTCACGCTTATGGTAGTGGG-3’, reverse:
5’-AGCAACTGAACACCACCTTCT-3’. HIPK2 forward:
5’- CACAGGCTCAAGATGGCAGA-3’, reverse: 5’-GGG
ATGTTCTTGCTCTGGCT-3’. HOXA4 forward: 5’-AG
AAGATCCATGTCAGCGCC-3’, reverse: 5’-TGTTGGG
CAGTTTGTGGTCT-3’. MLL3 forward: 5’- CTGCCAA
AGGAGACTCAGGG-3’, reverse: 5’- GTCCGTTTGCTT
CGCTGTTT-3’.
Additional file
Additional file 1: Supplementary data demonstrating effects
of short-term ethanol and acetaldehyde exposures at various
concentrations on OKF4 and OKF6 cell proliferation and candidate
miRNA expression. Figure S1. (A) OKF4 and OKF6 cell proliferation is
unaffected by ethanol exposure up to concentrations of 1 % over a 48-h
period. (B) OKF4 and OKF6 cell proliferation is unaffected by physiological
levels of acetaldehyde exposure over a 24-h period. (C) One-week
exposure of OKF4 to ethanol is sufficient to promote upregulation of
miR-934 and miR-3178. (PDF 436 kb)
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